drugset / Trial / NCT03055988
Cardiovascular Function in COPD Patients
RandomizedCrossoverDouble-blindTreatment
Summary
The objectives of the study are to explore the effect of treatment with tiotropium + olodaterol fixed dose combination (FDC) compared to fluticasone propionate + salmeterol FDC on: * reversal of left ventricular diastolic dysfunction assessed with cardiac magnetic resonance (CMR) imaging, * measures of arterial stiffness assessed by CMR and pulse wave analysis (PWA), * reduction of hyperinflation assessed with body plethysmography and * post dose spirometry.
Timeline
- Start
- 2017-03-29
- Primary completion
- 2018-03-05
- Completion
- 2018-03-26
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Fluticasone propionate | Other / unclassified | — | Inhaled |
| Subject | Olodaterol | Small molecule | — | Inhaled |
| Comparator | Salmeterol | Other / unclassified | — | Inhaled |
| Subject | Tiotropium | Other / unclassified | — | Inhaled |